170 related articles for article (PubMed ID: 10877512)
1. In-vitro activity of moxifloxacin combined with other antibacterials against methicillin-resistant Staphylococcus aureus.
Maggiolo F; Capra R; Bottura P; Pravettoni G; Migliorino M; Suter F
J Chemother; 2000 Jun; 12(3):195-8. PubMed ID: 10877512
[TBL] [Abstract][Full Text] [Related]
2. Activity of moxifloxacin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
Tarasi A; Cassone M; Monaco M; Tarasi D; Pompeo ME; Venditti M
J Chemother; 2003 Jun; 15(3):239-43. PubMed ID: 12868549
[TBL] [Abstract][Full Text] [Related]
3. Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance.
Entenza JM; Que YA; Vouillamoz J; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 2001 Nov; 45(11):3076-83. PubMed ID: 11600359
[TBL] [Abstract][Full Text] [Related]
4. Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-resistant and -susceptible Staphylococcus aureus strains.
Jones ME; Visser MR; Klootwijk M; Heisig P; Verhoef J; Schmitz FJ
Antimicrob Agents Chemother; 1999 Feb; 43(2):421-3. PubMed ID: 9925551
[TBL] [Abstract][Full Text] [Related]
5. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
Ertek M; Yazgi H; Aktaş E; Ayyildiz A; Parlak M
Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods.
Jacqueline C; Caillon J; Le Mabecque V; Miegeville AF; Donnio PY; Bugnon D; Potel G
J Antimicrob Chemother; 2003 Apr; 51(4):857-64. PubMed ID: 12654769
[TBL] [Abstract][Full Text] [Related]
7. Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilm.
Parra-Ruiz J; Vidaillac C; Rose WE; Rybak MJ
Antimicrob Agents Chemother; 2010 Oct; 54(10):4329-34. PubMed ID: 20696880
[TBL] [Abstract][Full Text] [Related]
8. Intracellular activity of ciprofloxacin and moxifloxacin, a new 8-methoxyquinolone, against methicillin-resistant Staphylococcus aureus.
Al-Nawas B; Shah PM
J Antimicrob Chemother; 1998 Jun; 41(6):655-8. PubMed ID: 9687105
[TBL] [Abstract][Full Text] [Related]
9. Ciprofloxacin- and methicillin-resistant staphylococcus aureus susceptible to moxifloxacin, levofloxacin, teicoplanin, vancomycin and linezolid.
Presterl E; Mueller-Uri P; Grisold A; Georgopoulos A; Graninger W
Eur J Clin Microbiol Infect Dis; 2001 Jul; 20(7):486-9. PubMed ID: 11561805
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of fluoroquinolones, vancomycin, and gentamicin against methicillin-resistant Staphylococcus aureus ocular isolates.
Kotlus BS; Wymbs RA; Vellozzi EM; Udell IJ
Am J Ophthalmol; 2006 Nov; 142(5):726-9. PubMed ID: 17056356
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial efficacy of gatifloxacin and moxifloxacin with and without benzalkonium chloride compared with ciprofloxacin and levofloxacin against methicillin-resistant Staphylococcus aureus.
Blondeau JM; Borsos S; Hesje CK
J Chemother; 2007 Apr; 19(2):146-51. PubMed ID: 17434822
[TBL] [Abstract][Full Text] [Related]
12. [In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis].
Soriano A; Jurado A; Marco F; Almela M; Ortega M; Mensa J
Rev Esp Quimioter; 2005 Jun; 18(2):168-72. PubMed ID: 16130039
[TBL] [Abstract][Full Text] [Related]
13. The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus.
Schmitz FJ; Fluit AC; Lückefahr M; Engler B; Hofmann B; Verhoef J; Heinz HP; Hadding U; Jones ME
J Antimicrob Chemother; 1998 Dec; 42(6):807-10. PubMed ID: 10052906
[TBL] [Abstract][Full Text] [Related]
14. In vitro potency of moxifloxacin, clinafloxacin and sitafloxacin against 248 genetically defined clinical isolates of Staphylococcus aureus.
Schmitz FJ; Fluit AC; Milatovic D; Verhoef J; Heinz HP; Brisse S
J Antimicrob Chemother; 2000 Jul; 46(1):109-13. PubMed ID: 10882698
[TBL] [Abstract][Full Text] [Related]
15. Effects of amoxicillin, gentamicin, and moxifloxacin on the hemolytic activity of Staphylococcus aureus in vitro and in vivo.
Worlitzsch D; Kaygin H; Steinhuber A; Dalhoff A; Botzenhart K; Döring G
Antimicrob Agents Chemother; 2001 Jan; 45(1):196-202. PubMed ID: 11120965
[TBL] [Abstract][Full Text] [Related]
16. In vitro killing of community-associated methicillin-resistant Staphylococcus aureus with drug combinations.
Shelburne SA; Musher DM; Hulten K; Ceasar H; Lu MY; Bhaila I; Hamill RJ
Antimicrob Agents Chemother; 2004 Oct; 48(10):4016-9. PubMed ID: 15388469
[TBL] [Abstract][Full Text] [Related]
17. Bactericidal activity of moxifloxacin compared to grepafloxacin and clarithromycin against Streptococcus pneumoniae and Streptococcus pyogenes investigated using an in vitro pharmacodynamic model.
Esposito S; Noviello S; Ianniello F
J Chemother; 2000 Dec; 12(6):475-81. PubMed ID: 11154028
[TBL] [Abstract][Full Text] [Related]
18. In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus.
Grohs P; Kitzis MD; Gutmann L
Antimicrob Agents Chemother; 2003 Jan; 47(1):418-20. PubMed ID: 12499229
[TBL] [Abstract][Full Text] [Related]
19. Assessment by time-kill methodology of the synergistic effects of oritavancin in combination with other antimicrobial agents against Staphylococcus aureus.
Belley A; Neesham-Grenon E; Arhin FF; McKay GA; Parr TR; Moeck G
Antimicrob Agents Chemother; 2008 Oct; 52(10):3820-2. PubMed ID: 18644953
[TBL] [Abstract][Full Text] [Related]
20. Bactericidal activity of moxifloxacin against Staphylococcus aureus.
Berrington AW; Perry JD; Gould FK
Clin Microbiol Infect; 2001 Mar; 7(3):161-3. PubMed ID: 11318816
[No Abstract] [Full Text] [Related]
[Next] [New Search]